Table 3 Clinical, serological, pathological, and bacteriological parameters in Sentinels
| Study Site | Kenya (VSRI) | Zambia (CVRI) | ||||||
|---|---|---|---|---|---|---|---|---|
| Treatment | Sentinel Saline | Sentinel Tulathromycin | Sentinel Gamithromycin | Sentinel Oxytetracycline | Sentinel Saline | Sentinel Tulathromycin | Sentinel Gamithromycin | Sentinel Oxytetracycline |
| Number of Cattle | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 |
| Max. number of pyrexia days | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Number euthanased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Max. CFT titer | 640 b | 10 | 10 | 0 | 80 | 80 | 0 | 0 |
| Number with acute/subacute or chronic lesions | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Number (%) with Mycoplasma isolated from tissue, pleural fluid or BAL | 1/5 (20%) | 0 | 0 | 0 | 2/5 (40%) | 0 | 0 | 0 |
| Number (%) with Mycoplasma isolated from nasal swabs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1/5 (20%) |
| Average HT lesion score (s.d.)a | 1.20 (2.68) | 0 | 0 | 0 | 1.60 (2.19) | 0 | 0 | 0 |